バイオマーカー探索アウトソーシングサービス市場、規模、シェア、動向、産業分析レポート：タイプ別、治療分野別、探索フェーズ別、最終用途別、地域別、2025年～2034年の市場予測

Polaris Market Research社の最新調査によると、バイオマーカー探索アウトソーシングサービスの世界市場規模は2034年までに839億3,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

バイオマーカー探索アウトソーシングサービスは、疾病診断、医薬品開発、個別化医療において重要な役割を果たすバイオマーカーの同定、検証、開発を第三者機関と契約して行うものです。このようなサービスは、医薬品開発業務受託機関（CRO）、バイオテクノロジー企業、専門研究所によって提供され、製薬企業やヘルスケア企業は次世代シーケンシング、プロテオミクス、バイオインフォマティクスなどの先端技術を利用できます。バイオマーカー探索をアウトソーシングすることで、企業は研究開発（R&D）の効率を最適化し、運営コストを削減し、新治療法の市場投入までの時間を短縮することができます。精密医療と標的治療への注目が高まるにつれ、バイオマーカーは治療に対する患者固有の反応を特定し、臨床試験の成功率を高めるのに役立つため、こうしたサービスに対する需要が大幅に高まっています。バイオマーカー探索アウトソーシングサービス市場は、研究協力の増加、ヘルスケア投資の増加、バイオマーカーに基づく診断の進歩により、着実な成長を遂げています。

バイオマーカー探索アウトソーシングサービス市場は、技術の進歩、堅調な製薬部門、支持的な規制の枠組みによって大きな成長を遂げています。主な促進要因としては、バイオマーカー分析を強化するための人工知能（AI）や機械学習の採用の増加、多様な研究ニーズに対応するためのサービスポートフォリオの拡大などが挙げられます。また、開発企業は効率と競合を改善するため、医薬品開発企業との戦略的提携を優先しています。個別化医療とバイオマーカー主導の医薬品開発への注目の高まりは市場開拓をさらに加速し、疾患検出と治療の最適化における革新的ソリューションの機会を生み出しています。精密医療への需要が高まる中、生物医学研究と治療開発を前進させる最先端のツールとサービスを提供する市場は、継続的な発展を遂げる態勢を整えています。

バイオマーカー探索アウトソーシングサービス市場レポートハイライト

タイプ別では、サロゲートエンドポイントが最大の市場シェアを占める。サロゲートエンドポイントは、臨床転帰を表す間接的な指標として機能し、研究者が医薬品開発中に治療の有効性と安全性をより効率的に評価できるようにします。

治療分野別では、がん領域がバイオマーカー探索アウトソーシングサービス市場を独占しています。これは、がん罹患率の増加とバイオマーカー主導型医薬品開発の採用拡大が背景にあります。がんの早期発見、予後予測、治療選択におけるバイオマーカーの利用が、臨床研究における同分野の重要性を高めています。

北米が最大の市場シェアを占めています。この優位性は、充実した研究開発投資、精密医療の重視、製薬企業と医薬品開発業務受託機関（CRO）の強固な協力関係によってもたらされています。

バイオマーカー探索アウトソーシングサービス市場のCAGRが最も高いのはアジア太平洋地域です。この急速な拡大は、製薬企業の研究開発活動の増加、臨床試験業務の急増、中国やインドなどの国々で利用可能な費用対効果の高いアウトソーシングソリューションに起因しています。

バイオマーカー探索アウトソーシングサービス市場の主要企業には、Laboratory Corporation of America Holdings（Labcorp）、Charles River Laboratories International, Inc.、Eurofins Scientific、Celerion、ICON plc、Parexel International（MA）Corporation、Proteome Sciences、Thermo Fisher Scientific Inc.、Evotec、WuXi AppTec、GenScript ProBio、Fujirebio Holdings Inc.などが含まれます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界バイオマーカー探索アウトソーシングサービス市場の洞察

• 市場スナップショット
• バイオマーカー探索アウトソーシングサービス市場力学
  • 促進要因と機会
    • 慢性疾患の有病率の上昇
    • オミクス技術の進歩
  • 抑制要因と課題
    • バイオマーカー検証の高コストと複雑さ
• PESTEL分析
• バイオマーカー探索アウトソーシングサービス市場動向
• バリューチェーン分析
• COVID-19の影響分析

第5章 世界のバイオマーカー探索アウトソーシングサービス市場：タイプ別

• 主な調査結果
• イントロダクション
• 予測バイオマーカー
• 予後バイオマーカー
• 安全性バイオマーカー
• 代替エンドポイント

第6章 世界のバイオマーカー探索アウトソーシングサービス市場：治療分野別

• 主な調査結果
• イントロダクション
• 腫瘍学
• 神経学
• 心臓病学
• 自己免疫疾患
• その他

第7章 世界のバイオマーカー探索アウトソーシングサービス市場：探索フェーズ別

• 主な調査結果
• イントロダクション
• バイオマーカーの同定
• バイオマーカー検証
• バイオマーカープロファイリング
• バイオマーカーパネル開発
• バイオマーカーの選択

第8章 世界のバイオマーカー探索アウトソーシングサービス市場：最終用途別

• 主な調査結果
• イントロダクション
• 製薬会社
• バイオテクノロジー企業
• その他

第9章 世界のバイオマーカー探索アウトソーシングサービス市場：地域

• 主な調査結果
• イントロダクション
  • バイオマーカー探索アウトソーシングサービス市場評価：地域、2020-2034年
• 北米
  • 北米：タイプ別、2020～2034年
  • 北米：治療領域別、2020～2034年
  • 北米：発見段階別、2020～2034年
  • 北米：最終用途別、2020～2034年
  • 米国
  • カナダ
• 欧州
  • 欧州：タイプ別、2020～2034年
  • 欧州：治療領域別、2020～2034年
  • 欧州：発見段階別、2020～2034年
  • 欧州：最終用途別、2020～2034年
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • スペイン
  • オランダ
  • ロシア
  • その他欧州
• アジア太平洋
  • アジア太平洋地域：タイプ別、2020～2034年
  • アジア太平洋地域：治療領域別、2020年～2034年
  • アジア太平洋地域：発見段階別、2020～2034年
  • アジア太平洋地域：最終用途別、2020～2034年
  • 中国
  • インド
  • マレーシア
  • 日本
  • インドネシア
  • 韓国
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ
  • 中東・アフリカ：タイプ別、2020～2034年
  • 中東・アフリカ：治療領域別、2020～2034年
  • 中東・アフリカ：発見段階別、2020～2034年
  • 中東・アフリカ：最終用途別、2020～2034年
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他中東とアフリカ
• ラテンアメリカ
  • ラテンアメリカ：タイプ別、2020-2034年
  • ラテンアメリカ：治療領域別、2020-2034年
  • ラテンアメリカ：発見段階別、2020～2034年
  • ラテンアメリカ：最終用途別、2020～2034年
  • メキシコ
  • ブラジル
  • アルゼンチン
  • その他ラテンアメリカ

第10章 競合情勢

• 拡大と買収の分析
  • 拡大
  • 買収
• 提携/協業/合意/公開

第11章 企業プロファイル

• Celerion
• Charles River Laboratories International, Inc.
• Eurofins Scientific
• Evotec
• Fujirebio Holdings Inc.
• GenScript ProBio
• ICON plc
• Laboratory Corporation of America Holdings（Labcorp）
• Parexel International（MA）Corporation
• Proteome Sciences
• Thermo Fisher Scientific Inc.
• WuXi AppTec

List of Tables:

• Table 1 Global Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
• Table 2 Global Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 3 Global Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
• Table 4 Global Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
• Table 5 North America: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
• Table 6 North America: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 7 North America: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
• Table 8 North America: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
• Table 9 U.S.: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
• Table 10 U.S.: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 11 U.S.: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
• Table 12 U.S.: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
• Table 13 Canada: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
• Table 14 Canada: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 15 Canada: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
• Table 16 Canada: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
• Table 17 Europe: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
• Table 18 Europe: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 19 Europe: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
• Table 20 Europe: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
• Table 21 UK: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
• Table 22 UK: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 23 UK: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
• Table 24 UK: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
• Table 25 France: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
• Table 26 France: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 27 France: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
• Table 28 France: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
• Table 29 Germany: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
• Table 30 Germany: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 31 Germany: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
• Table 32 Germany: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
• Table 33 Italy: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
• Table 34 Italy: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 35 Italy: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
• Table 36 Italy: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
• Table 37 Spain: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
• Table 38 Spain: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 39 Spain: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
• Table 40 Spain: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
• Table 41 Netherlands: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
• Table 42 Netherlands: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 43 Netherlands: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
• Table 44 Netherlands: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
• Table 45 Russia: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
• Table 46 Russia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 47 Russia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
• Table 48 Russia: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
• Table 49 Rest of Europe: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
• Table 50 Rest of Europe: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 51 Rest of Europe: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
• Table 52 Rest of Europe: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
• Table 53 Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
• Table 54 Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 55 Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
• Table 56 Asia Pacific: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
• Table 57 China: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
• Table 58 China: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 59 China: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
• Table 60 China: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
• Table 61 India: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
• Table 62 India: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 63 India: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
• Table 64 India: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
• Table 65 Malaysia: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
• Table 66 Malaysia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 67 Malaysia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
• Table 68 Malaysia: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
• Table 69 Japan: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
• Table 70 Japan: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 71 Japan: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
• Table 72 Japan: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
• Table 73 Indonesia: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
• Table 74 Indonesia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 75 Indonesia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
• Table 76 Indonesia: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
• Table 77 South Korea: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
• Table 78 South Korea: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 79 South Korea: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
• Table 80 South Korea: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
• Table 81 Australia: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
• Table 82 Australia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 83 Australia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
• Table 84 Australia: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
• Table 85 Rest of Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
• Table 86 Rest of Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 87 Rest of Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
• Table 88 Rest of Asia Pacific: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
• Table 89 Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
• Table 90 Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 91 Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
• Table 92 Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
• Table 93 Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
• Table 94 Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 95 Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
• Table 96 Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
• Table 97 UAE: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
• Table 98 UAE: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 99 UAE: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
• Table 100 UAE: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
• Table 101 Israel: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
• Table 102 Israel: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 103 Israel: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
• Table 104 Israel: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
• Table 105 South Africa: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
• Table 106 South Africa: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 107 South Africa: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
• Table 108 South Africa: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
• Table 109 Rest of Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
• Table 110 Rest of Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 111 Rest of Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
• Table 112 Rest of Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
• Table 113 Latin America: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
• Table 114 Latin America: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 115 Latin America: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
• Table 116 Latin America: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
• Table 117 Mexico: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
• Table 118 Mexico: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 119 Mexico: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
• Table 120 Mexico: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
• Table 121 Brazil: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
• Table 122 Brazil: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 123 Brazil: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
• Table 124 Brazil: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
• Table 125 Argentina: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
• Table 126 Argentina: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 127 Argentina: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
• Table 128 Argentina: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
• Table 129 Rest of Latin America: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
• Table 130 Rest of Latin America: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 131 Rest of Latin America: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
• Table 132 Rest of Latin America: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)

List of Figures:

• Figure 1. Global Biomarker Discovery Outsourcing Services Market, 2020-2034 (USD Billion)
• Figure 2. Integrated Ecosystem
• Figure 3. Research Methodology: Top-Down & Bottom-Up Price
• Figure 4. Market by Geography
• Figure 5. Porter's Five Forces
• Figure 6. Market by Type
• Figure 7. Global Biomarker Discovery Outsourcing Services Market, by Type, 2024 & 2034 (USD Billion)
• Figure 8. Market by Therapeutic Area
• Figure 9. Global Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2024 & 2034 (USD Billion)
• Figure 10. Market by Discovery Phase
• Figure 11. Global Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2024 & 2034 (USD Billion)
• Figure 12. Market by End Use
• Figure 13. Global Biomarker Discovery Outsourcing Services Market, by End Use, 2024 & 2034 (USD Billion)

The global biomarker discovery outsourcing services market size is expected to reach USD 83.93 billion by 2034, according to a new study by Polaris Market Research. The report "Biomarker Discovery Outsourcing Services Market Size, Share, Trends, Industry Analysis Report: By Type (Predictive Biomarkers, Prognostic Biomarkers, Safety Biomarkers, and Surrogate Endpoints), Therapeutic Area, Discovery Phase, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Biomarker discovery outsourcing services involve contracting third-party organizations to identify, validate, and develop biomarkers that play a crucial role in disease diagnosis, drug development, and personalized medicine. These services are offered by contract research organizations (CROs), biotechnology firms, and specialized laboratories, providing pharmaceutical and healthcare companies access to advanced technologies such as next-generation sequencing, proteomics, and bioinformatics. By outsourcing biomarker discovery, companies can optimize research and development (R&D) efficiency, reduce operational costs, and accelerate the time-to-market for new therapies. The growing focus on precision medicine and targeted therapies has significantly increased the demand for these services, as biomarkers help in identifying patient-specific responses to treatments and improving clinical trial success rates. The biomarker discovery outsourcing services market is witnessing steady growth due to increasing research collaborations, rising healthcare investments, and advancements in biomarker-based diagnostics.

The biomarker discovery outsourcing services market is experiencing significant growth, fueled by advancements in technology, a robust pharmaceutical sector, and supportive regulatory frameworks. Key drivers include the increasing adoption of artificial intelligence (AI) and machine learning to enhance biomarker analysis, as well as the expansion of service portfolios to meet diverse research needs. Companies are also prioritizing strategic collaborations with drug developers to improve efficiency and competitiveness. The rising focus on personalized medicine and biomarker-driven drug development is further accelerating market expansion, creating opportunities for innovative solutions in disease detection and treatment optimization. As demand for precision medicine grows, the market is poised for continued progress, offering cutting-edge tools and services to advance biomedical research and therapeutic development.

Biomarker Discovery Outsourcing Services Market Report Highlights

By type, surrogate endpoints hold the largest market share. Surrogate endpoints serve as indirect measures representing clinical outcomes, enabling researchers to assess treatment efficacy and safety more efficiently during drug development.

By therapeutic area, oncology dominates the biomarker discovery outsourcing services market, driven by the increasing prevalence of cancer and the growing adoption of biomarker-driven drug development. The use of biomarkers in early cancer detection, prognosis, and treatment selection enhances the segment's significance in clinical research.

North America holds the largest market share. This dominance is driven by substantial R&D investments, a strong emphasis on precision medicine, and robust collaborations between pharmaceutical companies and contract research organizations (CROs).

Asia Pacific is experiencing the highest biomarker discovery outsourcing services market CAGR. This rapid expansion is attributed to increasing pharmaceutical R&D activities, a surge in clinical trial operations, and cost-effective outsourcing solutions available in countries such as China and India.

The biomarker discovery outsourcing services market key players include Laboratory Corporation of America Holdings (Labcorp), Charles River Laboratories International, Inc., Eurofins Scientific, Celerion, ICON plc, Parexel International (MA) Corporation, Proteome Sciences, Thermo Fisher Scientific Inc., Evotec, WuXi AppTec, GenScript ProBio, and Fujirebio Holdings Inc

Polaris Market Research has segmented biomarker discovery outsourcing services market report based on type, therapeutic area, discovery phase, end use, and region:

By Type Outlook (Revenue-USD Billion, 2020-2034)

Predictive Biomarkers

Prognostic Biomarkers

Safety Biomarkers

Surrogate Endpoints

By Therapeutic Area Outlook (Revenue-USD Billion, 2020-2034)

Oncology

Neurology

Cardiology

Autoimmune Diseases

Others

By Discovery Phase Outlook (Revenue-USD Billion, 2020-2034)

Biomarker Identification

Biomarker Validation

Biomarker Profiling

Biomarker Panel Development

Biomarker Selection

By End Use Outlook (Revenue-USD Billion, 2020-2034)

Pharmaceutical Companies

Biotechnology Companies

Others

By Regional Outlook (Revenue-USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

Suth Korea

Indnesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

Suth Africa

Rest of Middle East & Africa

Latin America

Mexic

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Biomarker Discovery Outsourcing Services Market Insights

• 4.1. Biomarker Discovery Outsourcing Services Market - Market Snapshot
• 4.2. Biomarker Discovery Outsourcing Services Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Rising Prevalence of Chronic Diseases
    • 4.2.1.2. Advancements in Omics Technologies
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. High cost and complexity of biomarker validation
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Biomarker Discovery Outsourcing Services Market Trends
• 4.6. Value Chain Analysis
• 4.7. COVID-19 Impact Analysis

5. Global Biomarker Discovery Outsourcing Services Market, by Type

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
• 5.3. Predictive biomarkers
  • 5.3.1. Global Biomarker Discovery Outsourcing Services Market, by Predictive biomarkers, by Region, 2020-2034 (USD Billion)
• 5.4. Prognostic biomarkers
  • 5.4.1. Global Biomarker Discovery Outsourcing Services Market, by Prognostic biomarkers, by Region, 2020-2034 (USD Billion)
• 5.5. Safety biomarkers
  • 5.5.1. Global Biomarker Discovery Outsourcing Services Market, by Safety biomarkers, by Region, 2020-2034 (USD Billion)
• 5.6. Surrogate endpoints
  • 5.6.1. Global Biomarker Discovery Outsourcing Services Market, by Surrogate endpoints, by Region, 2020-2034 (USD Billion)

6. Global Biomarker Discovery Outsourcing Services Market, by Therapeutic Area

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
• 6.3. Oncology
  • 6.3.1. Global Biomarker Discovery Outsourcing Services Market, by Oncology, by Region, 2020-2034 (USD Billion)
• 6.4. Neurology
  • 6.4.1. Global Biomarker Discovery Outsourcing Services Market, by Neurology, by Region, 2020-2034 (USD Billion)
• 6.5. Cardiology
  • 6.5.1. Global Biomarker Discovery Outsourcing Services Market, by Cardiology, by Region, 2020-2034 (USD Billion)
• 6.6. Autoimmune Diseases
  • 6.6.1. Global Biomarker Discovery Outsourcing Services Market, by Autoimmune Diseases, by Region, 2020-2034 (USD Billion)
• 6.7. Others
  • 6.7.1. Global Biomarker Discovery Outsourcing Services Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Biomarker Discovery Outsourcing Services Market, by Discovery Phase

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
• 7.3. Biomarker Identification
  • 7.3.1. Global Biomarker Discovery Outsourcing Services Market, by Biomarker Identification, by Region, 2020-2034 (USD Billion)
• 7.4. Biomarker Validation
  • 7.4.1. Global Biomarker Discovery Outsourcing Services Market, by Biomarker Validation, by Region, 2020-2034 (USD Billion)
• 7.5. Biomarker Profiling
  • 7.5.1. Global Biomarker Discovery Outsourcing Services Market, by Biomarker Profiling, by Region, 2020-2034 (USD Billion)
• 7.6. Biomarker Panel Development
  • 7.6.1. Global Biomarker Discovery Outsourcing Services Market, by Biomarker Panel Development, by Region, 2020-2034 (USD Billion)
• 7.7. Biomarker Selection
  • 7.7.1. Global Biomarker Discovery Outsourcing Services Market, by Biomarker Selection, by Region, 2020-2034 (USD Billion)

8. Global Biomarker Discovery Outsourcing Services Market, by End Use

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Global Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
• 8.3. Pharmaceutical Companies
  • 8.3.1. Global Biomarker Discovery Outsourcing Services Market, by Pharmaceutical Companies, by Region, 2020-2034 (USD Billion)
• 8.4. Biotechnology Companies
  • 8.4.1. Global Biomarker Discovery Outsourcing Services Market, by Biotechnology Companies, by Region, 2020-2034 (USD Billion)
• 8.5. Others
  • 8.5.1. Global Biomarker Discovery Outsourcing Services Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global Biomarker Discovery Outsourcing Services Market, by Geography

• 9.1. Key Findings
• 9.2. Introduction
  • 9.2.1. Biomarker Discovery Outsourcing Services Market Assessment, By Geography, 2020-2034 (USD Billion)
• 9.3. Biomarker Discovery Outsourcing Services Market - North America
  • 9.3.1. North America: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • 9.3.2. North America: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 9.3.3. North America: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • 9.3.4. North America: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • 9.3.5. Biomarker Discovery Outsourcing Services Market - US
    • 9.3.5.1. US: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
    • 9.3.5.2. US: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.3.5.3. US: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
    • 9.3.5.4. US: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • 9.3.6. Biomarker Discovery Outsourcing Services Market - Canada
    • 9.3.6.1. Canada: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
    • 9.3.6.2. Canada: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.3.6.3. Canada: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
    • 9.3.6.4. Canada: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
• 9.4. Biomarker Discovery Outsourcing Services Market - Europe
  • 9.4.1. Europe: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • 9.4.2. Europe: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 9.4.3. Europe: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • 9.4.4. Europe: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • 9.4.5. Biomarker Discovery Outsourcing Services Market - UK
    • 9.4.5.1. UK: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
    • 9.4.5.2. UK: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.4.5.3. UK: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
    • 9.4.5.4. UK: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • 9.4.6. Biomarker Discovery Outsourcing Services Market - France
    • 9.4.6.1. France: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
    • 9.4.6.2. France: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.4.6.3. France: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
    • 9.4.6.4. France: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • 9.4.7. Biomarker Discovery Outsourcing Services Market - Germany
    • 9.4.7.1. Germany: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
    • 9.4.7.2. Germany: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.4.7.3. Germany: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
    • 9.4.7.4. Germany: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • 9.4.8. Biomarker Discovery Outsourcing Services Market - Italy
    • 9.4.8.1. Italy: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
    • 9.4.8.2. Italy: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.4.8.3. Italy: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
    • 9.4.8.4. Italy: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • 9.4.9. Biomarker Discovery Outsourcing Services Market - Spain
    • 9.4.9.1. Spain: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
    • 9.4.9.2. Spain: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.4.9.3. Spain: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
    • 9.4.9.4. Spain: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • 9.4.10. Biomarker Discovery Outsourcing Services Market - Netherlands
    • 9.4.10.1. Netherlands: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
    • 9.4.10.2. Netherlands: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.4.10.3. Netherlands: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
    • 9.4.10.4. Netherlands: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • 9.4.11. Biomarker Discovery Outsourcing Services Market - Russia
    • 9.4.11.1. Russia: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
    • 9.4.11.2. Russia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.4.11.3. Russia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
    • 9.4.11.4. Russia: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • 9.4.12. Biomarker Discovery Outsourcing Services Market - Rest of Europe
    • 9.4.12.1. Rest of Europe: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
    • 9.4.12.2. Rest of Europe: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.4.12.3. Rest of Europe: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
    • 9.4.12.4. Rest of Europe: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
• 9.5. Biomarker Discovery Outsourcing Services Market - Asia Pacific
  • 9.5.1. Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • 9.5.2. Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 9.5.3. Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • 9.5.4. Asia Pacific: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • 9.5.5. Biomarker Discovery Outsourcing Services Market - China
    • 9.5.5.1. China: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
    • 9.5.5.2. China: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.5.5.3. China: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
    • 9.5.5.4. China: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • 9.5.6. Biomarker Discovery Outsourcing Services Market - India
    • 9.5.6.1. India: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
    • 9.5.6.2. India: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.5.6.3. India: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
    • 9.5.6.4. India: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • 9.5.7. Biomarker Discovery Outsourcing Services Market - Malaysia
    • 9.5.7.1. Malaysia: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
    • 9.5.7.2. Malaysia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.5.7.3. Malaysia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
    • 9.5.7.4. Malaysia: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • 9.5.8. Biomarker Discovery Outsourcing Services Market - Japan
    • 9.5.8.1. Japan: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
    • 9.5.8.2. Japan: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.5.8.3. Japan: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
    • 9.5.8.4. Japan: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • 9.5.9. Biomarker Discovery Outsourcing Services Market - Indonesia
    • 9.5.9.1. Indonesia: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
    • 9.5.9.2. Indonesia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.5.9.3. Indonesia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
    • 9.5.9.4. Indonesia: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • 9.5.10. Biomarker Discovery Outsourcing Services Market - South Korea
    • 9.5.10.1. South Korea: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
    • 9.5.10.2. South Korea: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.5.10.3. South Korea: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
    • 9.5.10.4. South Korea: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • 9.5.11. Biomarker Discovery Outsourcing Services Market - Australia
    • 9.5.11.1. Australia: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
    • 9.5.11.2. Australia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.5.11.3. Australia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
    • 9.5.11.4. Australia: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • 9.5.12. Biomarker Discovery Outsourcing Services Market - Rest of Asia Pacific
    • 9.5.12.1. Rest of Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
    • 9.5.12.2. Rest of Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.5.12.3. Rest of Asia Pacific: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
    • 9.5.12.4. Rest of Asia Pacific: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
• 9.6. Biomarker Discovery Outsourcing Services Market - Middle East & Africa
  • 9.6.1. Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • 9.6.2. Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 9.6.3. Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • 9.6.4. Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • 9.6.5. Biomarker Discovery Outsourcing Services Market - Saudi Arabia
    • 9.6.5.1. Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
    • 9.6.5.2. Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.6.5.3. Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
    • 9.6.5.4. Saudi Arabia: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • 9.6.6. Biomarker Discovery Outsourcing Services Market - UAE
    • 9.6.6.1. UAE: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
    • 9.6.6.2. UAE: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.6.6.3. UAE: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
    • 9.6.6.4. UAE: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • 9.6.7. Biomarker Discovery Outsourcing Services Market - Israel
    • 9.6.7.1. Israel: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
    • 9.6.7.2. Israel: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.6.7.3. Israel: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
    • 9.6.7.4. Israel: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • 9.6.8. Biomarker Discovery Outsourcing Services Market - South Africa
    • 9.6.8.1. South Africa: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
    • 9.6.8.2. South Africa: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.6.8.3. South Africa: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
    • 9.6.8.4. South Africa: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • 9.6.9. Biomarker Discovery Outsourcing Services Market - Rest of Middle East & Africa
    • 9.6.9.1. Rest of Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
    • 9.6.9.2. Rest of Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.6.9.3. Rest of Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
    • 9.6.9.4. Rest of Middle East & Africa: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
• 9.7. Biomarker Discovery Outsourcing Services Market - Latin America
  • 9.7.1. Latin America: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
  • 9.7.2. Latin America: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 9.7.3. Latin America: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
  • 9.7.4. Latin America: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • 9.7.5. Biomarker Discovery Outsourcing Services Market - Mexico
    • 9.7.5.1. Mexico: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
    • 9.7.5.2. Mexico: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.7.5.3. Mexico: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
    • 9.7.5.4. Mexico: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • 9.7.6. Biomarker Discovery Outsourcing Services Market - Brazil
    • 9.7.6.1. Brazil: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
    • 9.7.6.2. Brazil: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.7.6.3. Brazil: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
    • 9.7.6.4. Brazil: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • 9.7.7. Biomarker Discovery Outsourcing Services Market - Argentina
    • 9.7.7.1. Argentina: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
    • 9.7.7.2. Argentina: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.7.7.3. Argentina: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
    • 9.7.7.4. Argentina: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)
  • 9.7.8. Biomarker Discovery Outsourcing Services Market - Rest of Latin America
    • 9.7.8.1. Rest of Latin America: Biomarker Discovery Outsourcing Services Market, by Type, 2020-2034 (USD Billion)
    • 9.7.8.2. Rest of Latin America: Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 9.7.8.3. Rest of Latin America: Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2020-2034 (USD Billion)
    • 9.7.8.4. Rest of Latin America: Biomarker Discovery Outsourcing Services Market, by End Use, 2020-2034 (USD Billion)

10. Competitive Landscape

• 10.1. Expansion and Acquisition Analysis
  • 10.1.1. Expansion
  • 10.1.2. Acquisitions
• 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

• 11.1. Celerion
  • 11.1.1. Company Overview
  • 11.1.2. Financial Performance
  • 11.1.3. Product Benchmarking
  • 11.1.4. Recent Development
• 11.2. Charles River Laboratories International, Inc.
  • 11.2.1. Company Overview
  • 11.2.2. Financial Performance
  • 11.2.3. Product Benchmarking
  • 11.2.4. Recent Development
• 11.3. Eurofins Scientific
  • 11.3.1. Company Overview
  • 11.3.2. Financial Performance
  • 11.3.3. Product Benchmarking
  • 11.3.4. Recent Development
• 11.4. Evotec
  • 11.4.1. Company Overview
  • 11.4.2. Financial Performance
  • 11.4.3. Product Benchmarking
  • 11.4.4. Recent Development
• 11.5. Fujirebio Holdings Inc.
  • 11.5.1. Company Overview
  • 11.5.2. Financial Performance
  • 11.5.3. Product Benchmarking
  • 11.5.4. Recent Development
• 11.6. GenScript ProBio
  • 11.6.1. Company Overview
  • 11.6.2. Financial Performance
  • 11.6.3. Product Benchmarking
  • 11.6.4. Recent Development
• 11.7. ICON plc
  • 11.7.1. Company Overview
  • 11.7.2. Financial Performance
  • 11.7.3. Product Benchmarking
  • 11.7.4. Recent Development
• 11.8. Laboratory Corporation of America Holdings (Labcorp)
  • 11.8.1. Company Overview
  • 11.8.2. Financial Performance
  • 11.8.3. Product Benchmarking
  • 11.8.4. Recent Development
• 11.9. Parexel International (MA) Corporation
  • 11.9.1. Company Overview
  • 11.9.2. Financial Performance
  • 11.9.3. Product Benchmarking
  • 11.9.4. Recent Development
• 11.10. Proteome Sciences
  • 11.10.1. Company Overview
  • 11.10.2. Financial Performance
  • 11.10.3. Product Benchmarking
  • 11.10.4. Recent Development
• 11.11. Thermo Fisher Scientific Inc.
  • 11.11.1. Company Overview
  • 11.11.2. Financial Performance
  • 11.11.3. Product Benchmarking
  • 11.11.4. Recent Development
• 11.12. WuXi AppTec
  • 11.12.1. Company Overview
  • 11.12.2. Financial Performance
  • 11.12.3. Product Benchmarking
  • 11.12.4. Recent Development